Landos Biopharma News

Landos Biopharma | 10-Q: Quarterly report

May 9 08:37 ET

Landos Biopharma | DEFM14A: Definitive proxy statement relating to merger or acquisition

Apr 25 17:11 ET

Landos Biopharma | 10-K/A: Annual report (Amendment)

Apr 16 08:05 ET

Landos Biopharma | PREM14A: Preliminary proxy statements relating to merger or acquisition

Apr 15 17:20 ET

Landos Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(47.7%),Joseph Edelman(47.7%), etc.

Apr 10 16:53 ET

Landos Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Xontogeny, LLC(9.9%)

Apr 10 16:53 ET

Landos Biopharma | DEFA14A: Others

Mar 26 08:54 ET

Landos Biopharma | DEFA14A: Others

Mar 25 16:06 ET

Landos Biopharma | DEFA14A: Others

Mar 25 09:23 ET

Landos Biopharma | 8-K: Current report

Mar 25 08:58 ET

Landos Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 21 09:16 ET

Landos Biopharma | 10-K: Annual report

Mar 21 08:36 ET

Landos Biopharma | 8-K: Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results

Mar 21 08:11 ET

Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Cataldi Fabio

Mar 4 16:17 ET

Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Oakes Gregory

Mar 4 16:14 ET

Landos Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Josep Bassaganya-Riera(0%)

Feb 14 16:10 ET

Landos Biopharma | 8-K: Current report

Jan 4 00:00 ET

Landos Biopharma | 8-K: Current report

Nov 21, 2023 08:08 ET

Landos Biopharma: Q3 2023 Earnings Report

Nov 9, 2023 08:22 ET

Landos Biopharma | 8-K: Landos Biopharma Provides Company Update andReports Third Quarter 2023 Results

Nov 9, 2023 08:08 ET